SQZ Biotech Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

SQZ Biotech is a developer of a cell engineering technology designed to deliver a diverse set of materials into patient cells. It is a privately held company that develops cellular therapies for multiple indications using the proprietary CellSqueeze technology. Through internal research programs and external partnerships, SQZ’s unique cell engineering capabilities are being used to develop a new generation of cell therapies by engineering the immune system both through immune activation and immu

Company Highlights
Year Founded

2013

icon-altEmployees

18

Location (HQ)

USA

Since Last Funding

2 years 7 months

Monthly Website Visitors

1.1K

icon-altTotal Investment Amt

$200M

Last Funding Round

Grant

icon-altYoY Headcount Growth

-49.86%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Biotechnology

Biotechnology Research

Life Science

Therapeutics